Physician profile
Cindy B Ivanhoe
NPI 1740217397
$110,751.75
in general payments reported to CMS, 2019-2025
25 companies · $12K in 2025
The $12K reported for 2025 was more than what 98% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $18K · 2021: $19K · 2022: $21K · 2023: $3,399 · 2024: $8,846 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,975 · Food and Beverage: $7,591 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,625 · Travel and Lodging: $2,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,975.00 |
| Food and Beverage | $7,590.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,625.00 |
| Travel and Lodging | $2,042.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $36,879.01 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $22,636.96 | 2019-2025 | Dysport |
| Abbvie INC. | $20,307.85 | 2022-2025 | |
| Shionogi INC | $10,398.05 | 2020 | |
| Saol Therapeutics INC. | $4,583.61 | 2019-2021 | |
| Medtronic USA, INC. | $4,122.06 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $4,088.60 | 2021-2025 | Xeomin |
| Medtronic, INC. | $2,187.31 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Activa PC |
| Flowonix Medical Incorporated | $2,153.96 | 2020-2022 | |
| Ipsen Pharma Sas | $1,264.89 | 2022 | |
| Merz North America, INC. | $492.35 | 2019-2020 | |
| Spinal Simplicity, LLC | $204.17 | 2023 | Ha Minuteman G3-R |
| Microtransponder, INC. | $162.25 | 2023 | |
| Saluda Medical Americas, INC. | $158.51 | 2024 | Evoke |
| Nevro Corp. | $149.67 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $149.31 | 2024 | Nuedexta |
| Pacira Pharmaceuticals Incorporated | $117.60 | 2025 | Iovera |
| Nalu Medical, INC. | $117.02 | 2024 | Nalu Neurostimulation System |
| Abbott Laboratories | $116.41 | 2024 | Proclaim |
| Novo Nordisk INC | $110.99 | 2022 | |
| Globus Medical, INC. | $105.44 | 2025 | Senza |
| Grt US Holding, INC. | $96.94 | 2022 | |
| Boston Scientific Corporation | $91.97 | 2025 | General - Pain Management |
| Revance Therapeutics, INC. | $37.85 | 2025 | Daxxify |
| Piramal Critical Care | $18.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Ivanhoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.